Skip to main content
Back to Current Affairs
PolitySource: Press Information Bureau

Union Health Minister Shri Jagat Prakash Nadda launches National Mass Drug Administration Round for the elimination of Lymphatic Filariasis across 13 identified LF endemic states

Tuesday, 11 February 2025
Read Original Article

Key Points

Last Updated: 2025-02-11 — Union Health Minister Shri Jagat Prakash Nadda has launched the Annual Nationwide Mass Drug Administration (MDA) Campaign to eliminate Lymphatic Filariasis across 13 endemic states. This initiative is crucial for UPSC aspirants as it relates to GS Paper 2, focusing on health and social justice.

Key Facts About National Mass Drug Administration Round

  • Launch Date: February 10
  • Target Year: 2027 for LF elimination
  • Coverage: 111 endemic districts
  • Population Protected: Over 175 million
  • Medicines Used: Diethylcarbamazine Citrate, Albendazole, Ivermectin
  • Key Symptoms: Lymphoedema, Hydrocele
  • Important Note: Not for children under 2, pregnant women, or those with serious illnesses
  • Integration: MMDP into Ayushman Arogya Mandir

India's Public Health Initiatives

The launch of the National Mass Drug Administration Round is a significant step towards improving public health in India, aligning with the country's strategic goal of eliminating Lymphatic Filariasis by 2027. This initiative supports India's commitment to the WHO's global target of eliminating LF as a public health problem. With over 175 million people targeted, this campaign is a testament to India's robust health infrastructure and its capacity to mobilize resources for large-scale health interventions.

Related Government Schemes/Policies

  • Ayushman Bharat: Provides health coverage to economically vulnerable Indians.
  • National Health Mission: Aims to provide accessible, affordable, and quality healthcare to the rural population.

UPSC Relevance

  • GS Paper 2: Health, Government Policies and Interventions
  • Prelims Angle: Questions on the drugs used, target year, and the number of states involved
  • Mains Angle: Analytical themes on public health initiatives and their impact on social justice

FAQ Section

  • What is Lymphatic Filariasis? Lymphatic Filariasis is a parasitic disease caused by microscopic, thread-like worms. It leads to symptoms like lymphoedema and hydrocele.
  • Why is the National Mass Drug Administration important? The campaign is crucial for eliminating Lymphatic Filariasis in India by 2027, protecting over 175 million people.
  • What are the key features of the campaign? The campaign involves administering Diethylcarbamazine Citrate, Albendazole, and Ivermectin to achieve over 90% coverage in 111 districts.

Detailed Coverage

  • Launch Date: February 10
  • Target Year: 2027 for LF elimination
  • Coverage: 111 endemic districts
  • Population Protected: Over 175 million
  • Medicines Used: Diethylcarbamazine Citrate, Albendazole, Ivermectin
  • Key Symptoms: Lymphoedema, Hydrocele
  • Important Note: Not for children under 2, pregnant women, or those with serious illnesses
  • Integration: MMDP into Ayushman Arogya Mandir
  • Hydrocele Surgeries: Nearly 50% in endemic states
  • Campaign Goals: Achieve 90% coverage
  • Government Approach: Whole-of-government support
  • Engagement: Various ministries involved
  • Community Awareness: Through IEC initiatives
  • States Involved: 13 states including Andhra Pradesh, Bihar, and West Bengal
  • Commitment: Towards an LF-free India
  • Conclusion: Aiming for a disease-free future by 2027
D1

Practice Questions

Test your understanding of this article

Question 1 of 50 / 5 answered
1

In the context of public health initiatives aimed at eradicating neglected tropical diseases, which term refers to the systematic administration of anti-filarial medications to entire populations in endemic areas, designed to interrupt the transmission of Lymphatic Filariasis by eliminating the parasites from the bloodstream?